Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Packaging
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Analysis

Debiopharm International

14-Jul-2018
Research & Development | Pharmaceutical

Companies

  • Debiopharm International

Related Content

Debiopharm continues fight against antibiotic resistance
Debiopharm continues fight against antibiotic resistance
Debiopharm acquires FibroTrap sample processing technology from Spinomix
Debiopharm acquires FibroTrap sample processing technology from Spinomix
Debiopharm and Nobelex Biotech to develop antibiotics against N. Gonorrhoeae and enteric species
Debiopharm and Nobelex Biotech to develop antibiotics against N. Gonorrhoeae and enteric species
Evotec and Debiopharm to collaborate on development of new cancer treatment
Evotec and Debiopharm to collaborate on development of new cancer treatment
Debiopharm aims to expand activities at its manufacturing facility in Martigny, Switzerland
Debiopharm aims to expand activities at its manufacturing facility in Martigny, Switzerland
Debiopharm Group and TCG Lifesciences to develop new class of antibiotics
Debiopharm Group and TCG Lifesciences to develop new class of antibiotics
Debiopharm to support Ascepion in development of cancer treatment
Debiopharm to support Ascepion in development of cancer treatment
Debiopharm has a management reshuffle
Debiopharm has a management reshuffle
Debiopharm and Yale University sign worldwide agreement
Debiopharm and Yale University sign worldwide agreement
Novartis wins rights to hepatitis drug
Novartis wins rights to hepatitis drug
Pfizer and Debiopharm to co-develop skin cancer drug
Pfizer and Debiopharm to co-develop skin cancer drug
Debiopharm and Mercury to develop Debio 0930
Debiopharm and Mercury to develop Debio 0930
Debiopharm and MSM Protein Technologies sign oncology research agreement
Debiopharm and MSM Protein Technologies sign oncology research agreement
Debiopharm develops Hepatitis C  Debio-025
Debiopharm develops Hepatitis C Debio-025
Debiopharm begins phase II study for Alzheimer's cure
Debiopharm begins phase II study for Alzheimer's cure
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company